Literature DB >> 28879405

Infection control interventions affected by resource shortages: impact on the incidence of bacteremias caused by carbapenem-resistant pathogens.

E Kousouli1, O Zarkotou1,2, L Politi3, K Polimeri1, G Vrioni3, K Themeli-Digalaki1,2, A Tsakris3, S Pournaras4,5.   

Abstract

We evaluated an infection control (IC) program influenced by personnel and material resource shortages on the incidence of bloodstream infections (BSI) due to carbapenem-resistant Klebsiella pneumoniae (CRKP), Acinetobacter baumannii (CRAB), and Pseudomonas aeruginosa (CRPA) in an endemic region. Between January 2010 and December 2015, all BSI episodes caused by CRKP, CRAB, and CRPA were recorded. An IC bundle was implemented in January 2012. We evaluated the effect of the interventions on BSI rates between the pre-intervention (2010-2011) and intervention (2012-2013) periods, using an interrupted time-series model. From 2014, when interventions were still applied, BSI incidence was gradually increased. For this reason, we evaluated with a linear mixed effects model several factors possibly contributing to this increase for the years 2012-2015, which was considered as the intervention/follow-up period. During the study period, 351 patients with BSI were recorded, with a total of 538 episodes; the majority (83.6%) occurred in the intensive care unit (ICU). The BSI incidence rate per year during 2010-2015 for ICU patients was 21.03/19.63/17.32/14.45/22.85/25.02 per 1000 patient-days, respectively, with the reduction in BSI levels after the start of intervention marginal (p = 0.054). During the follow-up period (2014-2015), the most influential factors for the increased BSI incidence were the reduced participation in educational courses and compliance with hand hygiene. The implementation of IC interventions reduced the BSI incidence rates, particularly for ICU patients. However, factors possibly related to the restrictions of human and material resources apparently contributed to the observed expansion of BSI in our endemic setting.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28879405     DOI: 10.1007/s10096-017-3098-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  23 in total

Review 1.  Minimum requirements in infection control.

Authors:  J Rodríguez-Baño; M D del Toro; J López-Méndez; N T Mutters; A Pascual
Journal:  Clin Microbiol Infect       Date:  2015-09-10       Impact factor: 8.067

2.  Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015.

Authors:  Barbara Albiger; Corinna Glasner; Marc J Struelens; Hajo Grundmann; Dominique L Monnet
Journal:  Euro Surveill       Date:  2015

3.  The Effect of a Nationwide Infection Control Program Expansion on Hospital-Onset Gram-Negative Rod Bacteremia in 130 Veterans Health Administration Medical Centers: An Interrupted Time-Series Analysis.

Authors:  Michihiko Goto; Amy M J O'Shea; Daniel J Livorsi; Jennifer S McDanel; Makoto M Jones; Kelly K Richardson; Brice F Beck; Bruce Alexander; Martin E Evans; Gary A Roselle; Stephen M Kralovic; Eli N Perencevich
Journal:  Clin Infect Dis       Date:  2016-06-28       Impact factor: 9.079

4.  Recommendations on basic requirements for intensive care units: structural and organizational aspects.

Authors:  Andreas Valentin; Patrick Ferdinande
Journal:  Intensive Care Med       Date:  2011-09-15       Impact factor: 17.440

5.  Costs and possible benefits of a two-tier infection control management strategy consisting of active screening for multidrug-resistant organisms and tailored control measures.

Authors:  N T Mutters; F Günther; U Frank; A Mischnik
Journal:  J Hosp Infect       Date:  2016-03-03       Impact factor: 3.926

6.  Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study.

Authors:  Hajo Grundmann; Corinna Glasner; Barbara Albiger; David M Aanensen; Chris T Tomlinson; Arjana Tambić Andrasević; Rafael Cantón; Yehuda Carmeli; Alexander W Friedrich; Christian G Giske; Youri Glupczynski; Marek Gniadkowski; David M Livermore; Patrice Nordmann; Laurent Poirel; Gian M Rossolini; Harald Seifert; Alkiviadis Vatopoulos; Timothy Walsh; Neil Woodford; Dominique L Monnet
Journal:  Lancet Infect Dis       Date:  2016-11-18       Impact factor: 25.071

Review 7.  ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients.

Authors:  E Tacconelli; M A Cataldo; S J Dancer; G De Angelis; M Falcone; U Frank; G Kahlmeter; A Pan; N Petrosillo; J Rodríguez-Baño; N Singh; M Venditti; D S Yokoe; B Cookson
Journal:  Clin Microbiol Infect       Date:  2014-01       Impact factor: 8.067

8.  Intensive care unit-acquired infections in a tertiary care hospital: An epidemiologic survey and influence on patient outcomes.

Authors:  Sanwar M Mitharwal; Sandhya Yaddanapudi; Neerja Bhardwaj; Vikas Gautam; Manisha Biswal; Lakshminarayana Yaddanapudi
Journal:  Am J Infect Control       Date:  2016-03-02       Impact factor: 2.918

9.  A combined disk test for direct differentiation of carbapenemase-producing enterobacteriaceae in surveillance rectal swabs.

Authors:  Spyros Pournaras; Olympia Zarkotou; Aggeliki Poulou; Ioulia Kristo; Georgia Vrioni; Katerina Themeli-Digalaki; Athanassios Tsakris
Journal:  J Clin Microbiol       Date:  2013-07-10       Impact factor: 5.948

10.  Pseudomonas aeruginosa in a neonatal intensive care unit: molecular epidemiology and infection control measures.

Authors:  Valeria Crivaro; Anna Di Popolo; Alessandro Caprio; Antonietta Lambiase; Mario Di Resta; Tonia Borriello; Alda Scarcella; Maria Triassi; Raffaele Zarrilli
Journal:  BMC Infect Dis       Date:  2009-05-22       Impact factor: 3.090

View more
  6 in total

1.  Reducing dissemination of carbapenem-resistant Klebsiella pneumoniae.

Authors:  Matteo Bassetti; Daniele Roberto Giacobbe
Journal:  Ann Transl Med       Date:  2019-12

2.  Containing Carbapenemase-producing Klebsiella pneumoniae in an endemic setting.

Authors:  Kalliopi Spyridopoulou; Mina Psichogiou; Vana Sypsa; Vivi Miriagou; Amalia Karapanou; Linos Hadjihannas; Leonidas Tzouvelekis; George L Daikos
Journal:  Antimicrob Resist Infect Control       Date:  2020-07-06       Impact factor: 4.887

3.  Bloodstream infections due to carbapenemase-producing Enterobacteriaceae in Italy: results from nationwide surveillance, 2014 to 2017.

Authors:  Simone Iacchini; Michela Sabbatucci; Carlo Gagliotti; Gian Maria Rossolini; Maria Luisa Moro; Stefania Iannazzo; Fortunato D'Ancona; Patrizio Pezzotti; Annalisa Pantosti
Journal:  Euro Surveill       Date:  2019-01

4.  Gastrointestinal Carriage of Vancomycin-Resistant Enterococci and Carbapenem-Resistant Gram-Negative Bacteria in an Endemic Setting: Prevalence, Risk Factors, and Outcomes.

Authors:  Alexandra Vasilakopoulou; Polyxeni Karakosta; Sophia Vourli; Aikaterini Tarpatzi; Paraskevi Varda; Maria Kostoula; Anastasia Antoniadou; Spyros Pournaras
Journal:  Front Public Health       Date:  2020-03-18

5.  Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study.

Authors:  Elisangela M Lima; Patrícia A Cid; Debora S Beck; Luiz Henrique Z Pinheiro; João Pedro S Tonhá; Marcio Z O Alves; Newton D Lourenço; Roberto Q Santos; Marise D Asensi; José Aurélio Marques; Carolina S Bandeira; Caio Augusto S Rodrigues; Saint Clair S Gomes Junior; Marisa Z R Gomes
Journal:  Antimicrob Resist Infect Control       Date:  2020-08-14       Impact factor: 4.887

6.  Impact of bloodstream infections caused by carbapenem-resistant Gram-negative pathogens on ICU costs, mortality and length of stay.

Authors:  E Kousouli; O Zarkotou; K Polimeri; K Themeli-Digalaki; S Pournaras
Journal:  Infect Prev Pract       Date:  2019-08-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.